Antibody to Bevacizumab ELISA
Enzyme immunoassay for the semi-quantitative determination of free antibodies to Bevacizumab (Avastin®) in serum and plasma.
The solid phase (MTP) is coated by the drug Bevacizumab. Due to the assay design this test only measures the free antibodies which are not bound to Bevacizumab. Results are expressed in AU (arbitrary units).
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Avastin® is a trademark of Genentech Inc./Roche.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||135|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Results in||Arbitrary Units (AU/mL)|
|Shelf Life (years)||2|